Recalls are typically voluntary actions taken by a company to remove or correct products on the market that violate U.S. Food and Drug Administration laws and regulations. Recalls may be initiated proactively by a company, at FDA request, or ordered under statutory authority.
Similar Posts
Olympus Issues Voluntary Recall for Specific Lots of ViziShot 2 FLEX (19G) EBUS -TBNA Needles
CENTER VALLEY, Pa., (September 19, 2025) — Olympus Corporation has announced a voluntary, global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) manufactured prior to May 12, 2025, after receiving reports of device components detaching during proceduresFind Information about a Drug
Information on FDA-approved drugs released for sale on the market, such as dosage, side effects, and disposal methodsPurushothaman Damodara Kumaran, M.D. – 721325 – 12/22/2025
In Vivo Bioavailability-Bioequivalence Studies – ClinicalNavitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk
Navitas Organics is voluntarily recalling select lots of its 8oz Organic Chia Seeds due to possible Salmonella contamination. This recall is being conducted as a precautionary measure following a recall initiated by the company’s chia seed supplier.Weight Loss, Male Enhancement and Other Products Sold Online or in Stores May Be Dangerous
Consumers cannot be confident that certain products, including weight loss and male enhancement products, sold on online marketplaces like Amazon and eBay or in stores, are safe to use.FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae
FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae